310 related articles for article (PubMed ID: 24557813)
1. Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.
Starling AP; Engel SM; Richardson DB; Baird DD; Haug LS; Stuebe AM; Klungsøyr K; Harmon Q; Becher G; Thomsen C; Sabaredzovic A; Eggesbø M; Hoppin JA; Travlos GS; Wilson RE; Trogstad LI; Magnus P; Longnecker MP
Am J Epidemiol; 2014 Apr; 179(7):824-33. PubMed ID: 24557813
[TBL] [Abstract][Full Text] [Related]
2. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
[TBL] [Abstract][Full Text] [Related]
3. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
[TBL] [Abstract][Full Text] [Related]
4. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with hypertensive disorders of pregnancy in the Atlanta African American Maternal-Child cohort.
Thompson M; Eatman JA; Dunlop AL; Barr DB; Kannan K; Corwin EJ; Ryan PB; Panuwet P; Yakimavets V; Taibl KR; Tan Y; Liang D; Eick SM
Chemosphere; 2024 Jun; 357():142052. PubMed ID: 38631500
[TBL] [Abstract][Full Text] [Related]
5. Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study).
Singer AB; Whitworth KW; Haug LS; Sabaredzovic A; Impinen A; Papadopoulou E; Longnecker MP
Environ Res; 2018 Oct; 166():78-85. PubMed ID: 29879567
[TBL] [Abstract][Full Text] [Related]
6. Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women.
Wikström S; Lindh CH; Shu H; Bornehag CG
Sci Rep; 2019 Jun; 9(1):9179. PubMed ID: 31235847
[TBL] [Abstract][Full Text] [Related]
7. Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women.
Brantsæter AL; Whitworth KW; Ydersbond TA; Haug LS; Haugen M; Knutsen HK; Thomsen C; Meltzer HM; Becher G; Sabaredzovic A; Hoppin JA; Eggesbø M; Longnecker MP
Environ Int; 2013 Apr; 54():74-84. PubMed ID: 23419425
[TBL] [Abstract][Full Text] [Related]
8. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive disorders of pregnancy.
Huang R; Chen Q; Zhang L; Luo K; Chen L; Zhao S; Feng L; Zhang J
Environ Health; 2019 Jan; 18(1):5. PubMed ID: 30626391
[TBL] [Abstract][Full Text] [Related]
9. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health.
Tsai MS; Miyashita C; Araki A; Itoh S; Bamai YA; Goudarzi H; Okada E; Kashino I; Matsuura H; Kishi R
Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29758015
[TBL] [Abstract][Full Text] [Related]
10. The association between perfluoroalkyl substances and lipid profile in exposed pregnant women in the Veneto region, Italy.
Dalla Zuanna T; Savitz DA; Barbieri G; Pitter G; Zare Jeddi M; Daprà F; Fabricio ASC; Russo F; Fletcher T; Canova C
Ecotoxicol Environ Saf; 2021 Feb; 209():111805. PubMed ID: 33360787
[TBL] [Abstract][Full Text] [Related]
11. The Association Between Perfluoroalkyl Substances and Lipids in Cord Blood.
Spratlen MJ; Perera FP; Lederman SA; Robinson M; Kannan K; Herbstman J; Trasande L
J Clin Endocrinol Metab; 2020 Jan; 105(1):43-54. PubMed ID: 31536623
[TBL] [Abstract][Full Text] [Related]
12. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women.
Ren Y; Jin L; Yang F; Liang H; Zhang Z; Du J; Song X; Miao M; Yuan W
Environ Health; 2020 Aug; 19(1):88. PubMed ID: 32807188
[TBL] [Abstract][Full Text] [Related]
13. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood.
Granum B; Haug LS; Namork E; Stølevik SB; Thomsen C; Aaberge IS; van Loveren H; Løvik M; Nygaard UC
J Immunotoxicol; 2013; 10(4):373-9. PubMed ID: 23350954
[TBL] [Abstract][Full Text] [Related]
14. Perfluoroalkyl substances and time to pregnancy in couples from Greenland, Poland and Ukraine.
Jørgensen KT; Specht IO; Lenters V; Bach CC; Rylander L; Jönsson BA; Lindh CH; Giwercman A; Heederik D; Toft G; Bonde JP
Environ Health; 2014 Dec; 13():116. PubMed ID: 25533644
[TBL] [Abstract][Full Text] [Related]
15. Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study.
Borghese MM; Walker M; Helewa ME; Fraser WD; Arbuckle TE
Environ Int; 2020 Aug; 141():105789. PubMed ID: 32408216
[TBL] [Abstract][Full Text] [Related]
16. Early-Life Exposure to Perfluoroalkyl Substances and Childhood Metabolic Function.
Fleisch AF; Rifas-Shiman SL; Mora AM; Calafat AM; Ye X; Luttmann-Gibson H; Gillman MW; Oken E; Sagiv SK
Environ Health Perspect; 2017 Mar; 125(3):481-487. PubMed ID: 27586368
[TBL] [Abstract][Full Text] [Related]
17. Perfluoroalkyl Substances during Pregnancy and Offspring Weight and Adiposity at Birth: Examining Mediation by Maternal Fasting Glucose in the Healthy Start Study.
Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Ye X; Dabelea D
Environ Health Perspect; 2017 Jun; 125(6):067016. PubMed ID: 28669937
[TBL] [Abstract][Full Text] [Related]
18. Prenatal exposure to perfluoroalkyl substances and the risk of congenital cerebral palsy in children.
Liew Z; Ritz B; Bonefeld-Jørgensen EC; Henriksen TB; Nohr EA; Bech BH; Fei C; Bossi R; von Ehrenstein OS; Streja E; Uldall P; Olsen J
Am J Epidemiol; 2014 Sep; 180(6):574-81. PubMed ID: 25139206
[TBL] [Abstract][Full Text] [Related]
19. Determinants of plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances in pregnant women from a birth cohort in Shanghai, China.
Tian Y; Zhou Y; Miao M; Wang Z; Yuan W; Liu X; Wang X; Wang Z; Wen S; Liang H
Environ Int; 2018 Oct; 119():165-173. PubMed ID: 29958117
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight.
Wikström S; Lin PI; Lindh CH; Shu H; Bornehag CG
Pediatr Res; 2020 May; 87(6):1093-1099. PubMed ID: 31835271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
